FINANCIAL COUNSELORS INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
FINANCIAL COUNSELORS INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$396,945
+98153.7%
25,659
-0.2%
0.01%0.0%
Q2 2023$404
-4.7%
25,699
-0.2%
0.01%
-11.1%
Q1 2023$424
+4.7%
25,756
-0.7%
0.01%0.0%
Q4 2022$405
-99.9%
25,947
-0.3%
0.01%
+12.5%
Q3 2022$338,000
-7.9%
26,032
-0.4%
0.01%
-11.1%
Q2 2022$367,000
-8.0%
26,149
-6.1%
0.01%
+12.5%
Q1 2022$399,000
+3.1%
27,836
-1.9%
0.01%0.0%
Q4 2021$387,000
-17.8%
28,378
-1.4%
0.01%
-20.0%
Q3 2021$471,000
-3.1%
28,784
-0.2%
0.01%
-9.1%
Q2 2021$486,000
-9.3%
28,850
-1.7%
0.01%
-8.3%
Q1 2021$536,0000.0%29,342
-0.3%
0.01%
-7.7%
Q4 2020$536,000
+1.7%
29,430
-0.4%
0.01%
-13.3%
Q3 2020$527,000
-1.3%
29,535
-0.9%
0.02%
-11.8%
Q2 2020$534,000
+17.9%
29,800
-0.2%
0.02%
-15.0%
Q1 2020$453,000
-23.9%
29,863
-0.9%
0.02%
-4.8%
Q4 2019$595,000
+14.0%
30,139
-0.6%
0.02%0.0%
Q3 2019$522,000
-3.0%
30,325
-0.2%
0.02%
-4.5%
Q2 2019$538,000
-14.1%
30,380
-1.1%
0.02%
-18.5%
Q1 2019$626,00030,7110.03%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders